A Aralex Aachen research explorer

July 29, 2015 article

Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets

Journal of Gastrointestinal Surgery

DOI: 10.1007/s11605-015-2890-4 OpenAlex

Authors 0

Author list not loaded yet.

Cited by 3 stored of 219

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial
2022 Journal of Clinical Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access

738

citations
External Validity of the Multicenter Randomized PREOPANC Trial on Neoadjuvant Chemoradiotherapy in Pancreatic Cancer
2020 Annals of Surgery article Medicine Pancreatic and Hepatic Oncology Research Open access

5

citations
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
2020 Journal of Clinical Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access cited by 1 patent

1,106

citations

3 results

References 0